Synthesis and Biological Evaluation of 2-(2-Deoxy-β-D-ribofuranosyl)pyridine-4-carboxamide
✍ Scribed by Pieter E. Joos; Eddy L. Esmans; Roger A. Dommisse; André De Bruyn; Jan M. Balzarini; Eric D. De Clercq
- Publisher
- John Wiley and Sons
- Year
- 1992
- Tongue
- German
- Weight
- 549 KB
- Volume
- 75
- Category
- Article
- ISSN
- 0018-019X
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
A new protected 2‐deoxy‐D‐ribose derivative, 5‐O‐[(tert‐butyl)diphenylsilyl]‐2‐deoxy‐3,4‐O‐ isopropylidene‐aldehydo‐D‐ribose (5), was synthesized starting from 2‐deoxy‐D‐ribose. This compound was coupled with 2‐lithio‐4‐(4,5‐dihydro‐4,4‐dimethyloxazol‐2‐yl)pyridine giving a D/L‐glycero‐mixture 7 of 5‐O‐[(tert‐butyl)diphenylsilyl]‐2‐deoxy‐1‐C‐[4‐(4,5 ‐dihydro‐4,4‐dimethyloxazol‐2‐yl)pyridin‐2‐yl]‐3,4‐O‐isopropylidene‐ D‐erythro‐pentitol. The mixture 7 was 1‐O‐mesylated with methanesulfonyl chloride and subsequently treated with CF~3~COOH/H~2~O and ammonia to afford the α/β‐D‐anomers 10 of 2‐(2‐deoxy‐D‐ribofuranosyl)pyridine‐4‐carboxamide. Both anomers were purified and separated by HPLC and identified by NMR and DCI‐MS. Anomer β‐D‐10 was evaluated against a series of tumor‐cell lines and a variety of viral strains. No antitumor or antiviral activity was observed.
📜 SIMILAR VOLUMES
Metallation of 5-ethynyl-1-(2,3,5-tri-O-terf-butyldimethylsilyl-~-~-ribof~anosyl)imidazole-4-carboxamide (1) using n-BuLi, deuteration with deuterium oxide and removal of the fertbutyldimethylsilyl protecting groups using tetrabutylammonium fluroide yielded [2-'H]-5ethynyl-1 -(~-D-ribofi1ranosyl)imi
## Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 100 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a “Full Text” option. The original article is trackable v